Literature DB >> 2945992

5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus.

R Markstein, D Hoyer, G Engel.   

Abstract

Serotonin (5-HT) stimulated adenylate cyclase activity in homogenates of rat hippocampus. This effect was pharmacologically characterised with a series of agonists and antagonists of various structural classes. These compounds where also tested in radioligand binding studies using selective ligands for the various subtypes of 5-HT1 and 5-HT2 receptors. 5-HT1A, 5-HT1B and 5-HT1C recognition sites were labelled with [3H]8-OH-DPAT([3H]8-hydroxy-2-(di-n-propylamino)-tetralin) in pig cortex membranes, [125I]CYP([125I]iodocyanopindolol) in rat cortex and [3H]mesulergine in pig choroid plexus membranes, respectively. The rank order of potency of 13 agonists stimulating adenylate cyclase activity in homogenates of rat hippocampus was in good agreement with the rank order of affinity of these agonists for the 5-HT1A binding site: N,N-dipropyl-5-carboxamidotryptamine (DP-5-CT) greater than 5-carboxamidotryptamine (5-CT) greater than 8-OH-DPAT greater than 5-HT greater than 5-methoxytryptamine (5-OCH3T) greater than d-LSD greater than 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole (RU 24969) greater than alpha-methylserotonin (alpha-CH3-5-HT) greater than dopamine greater than 2-methylserotonin (2-CH3-5-HT). The correlation between the respective potencies and affinities of these agonists was r = 0.934, P less than 0.001. There was no correlation between stimulation of adenylate cyclase activity by these agonists and their affinity for 5-HT1B, 5-HT1C or 5-HT2 binding sites. r = 0.381-0.108, P less than 0.20-0.73.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2945992     DOI: 10.1007/bf00500006

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  38 in total

1.  A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissues.

Authors:  E K Frandsen; G Krishna
Journal:  Life Sci       Date:  1976-03-01       Impact factor: 5.037

2.  Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.

Authors:  D Hoyer; G Engel; H O Kalkman
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

3.  Two 5-HT receptors linked to adenylate cyclase in guinea pig hippocampus are discriminated by 5-carboxamidotryptamine and spiperone.

Authors:  A Shenker; S Maayani; H Weinstein; J P Green
Journal:  Eur J Pharmacol       Date:  1985-03-12       Impact factor: 4.432

4.  Serotonin receptor binding sites affected differentially by guanine nucleotides.

Authors:  S J Peroutka; R M Lebovitz; S H Snyder
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

5.  Mesulergine and its 1,20-N,N-bidemethylated metabolite interact directly with D1- and D2-receptors.

Authors:  R Markstein
Journal:  Eur J Pharmacol       Date:  1983-11-11       Impact factor: 4.432

6.  Multiple 3H-5-hydroxytryptamine binding sites in rat brain.

Authors:  D L Nelson; N W Pedigo; H I Yamamura
Journal:  J Physiol (Paris)       Date:  1981

7.  Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT.

Authors:  H Gozlan; S El Mestikawy; L Pichat; J Glowinski; M Hamon
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

8.  Biochemical assessment of the central 5-HT agonist activity of RU 24969 (a piperidinyl indole).

Authors:  C Euvrard; J R Boissier
Journal:  Eur J Pharmacol       Date:  1980-04-11       Impact factor: 4.432

9.  Serotonin-sensitive adenylate cyclase and [3H]serotonin binding sites in the CNS of the rat--I.

Authors:  D L Nelson; A Herbet; A Enjalbert; J Bockaert; M Hamon
Journal:  Biochem Pharmacol       Date:  1980-09-15       Impact factor: 5.858

10.  Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.

Authors:  D Hoyer; A Pazos; A Probst; J M Palacios
Journal:  Brain Res       Date:  1986-06-18       Impact factor: 3.252

View more
  48 in total

1.  Regulation of 5-HT(1A) receptor-stimulated [35S]-GtpgammaS binding as measured by quantitative autoradiography following chronic agonist administration.

Authors:  J Hensler; H Durgam
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 2.  The recombinant 5-HT1A receptor: G protein coupling and signalling pathways.

Authors:  J R Raymond; Y V Mukhin; T W Gettys; M N Garnovskaya
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

3.  Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors.

Authors:  P A Pierce; J Y Kim; S J Peroutka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

Review 4.  The 5-HT1A receptor: an overview of recent advances.

Authors:  S el Mestikawy; A Fargin; J R Raymond; H Gozlan; M Hnatowich
Journal:  Neurochem Res       Date:  1991-01       Impact factor: 3.996

5.  Facilitation of serotonin (5-HT) release in the rat brain cortex by cAMP and probable inhibition of adenylate cyclase in 5-HT nerve terminals by presynaptic alpha 2-adrenoceptors.

Authors:  E Schlicker; K Fink; K Classen; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

6.  Characterization of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery.

Authors:  G J Molderings; G Engel; E Roth; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

Review 7.  A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.

Authors:  Jose M Palacios; Angel Pazos; Daniel Hoyer
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

8.  Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain.

Authors:  P C Waldmeier; M Williams; P A Baumann; S Bischoff; M A Sills; R F Neale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

9.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

10.  8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding sites in goldfish retina.

Authors:  L Lima; C Schmeer; M Urbina
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.